Document is current
Any future updates will be listed below
-
Authors
Dong, Zhen https://orcid.org/0000-0002-3480-3421
Xiang, Weirong
Jiang, Wenhao https://orcid.org/0009-0000-9381-9848
Guo, Tiannan https://orcid.org/0000-0003-3869-7651
-
Funding
Funding for this research was provided by:
MOST | National Natural Science Foundation of China (92259201)
State Key Laboratory of Medical Proteomics (SKLP-Y202405)
MOST | National Key Research and Development Program of China (2021YFA1301600)
Pioneer and Leading Goose R&D Program of Zhejiang (2024SSYS0035)
- License Information
-
More Information
Article History
Received: 10 November 2025
Revised: 12 November 2025
Accepted: 13 November 2025
First Online: 1 December 2025
Disclosure and competing interests statement
: TG is the shareholder of Westlake Omics (Hangzhou) Biotechnology Co., Ltd. The remaining authors declare no competing interests.
